Catalyst Pharmaceuticals Inc’s recent filing unveils that its Chief Med. & Reg. Officer INGENITO GARY unloaded Company’s shares for reported $0.27 million on Nov 27 ’24. In the deal valued at $22.72 per share,12,000 shares were sold. As a result of this transaction, INGENITO GARY now holds 51,391 shares worth roughly $1.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Harper Molly sold 17,500 shares, generating $385,000 in total proceeds. Upon selling the shares at $22.00, the Director now owns 0 shares.
Before that, Elsbernd Brian sold 13,256 shares. Catalyst Pharmaceuticals Inc shares valued at $286,704 were divested by the Chief Compliance/Legal Officer at a price of $21.63 per share. As a result of the transaction, Elsbernd Brian now holds 165,377 shares, worth roughly $3.6 million.
Stephens initiated its Catalyst Pharmaceuticals Inc [CPRX] rating to an Overweight in a research note published on November 18, 2024; the price target was $35. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. BofA Securities began covering CPRX with “Buy” recommendation on March 07, 2024. Oppenheimer started covering the stock on December 21, 2023. It rated CPRX as “an Outperform”.
Price Performance Review of CPRX
On Monday, Catalyst Pharmaceuticals Inc [NASDAQ:CPRX] saw its stock fall -1.27% to $21.74. Over the last five days, the stock has lost -3.51%. Catalyst Pharmaceuticals Inc shares have risen nearly 29.33% since the year began. Nevertheless, the stocks have risen 51.92% over the past one year. While a 52-week high of $24.27 was reached on 11/08/24, a 52-week low of $13.00 was recorded on 02/08/24. SMA at 50 days reached $21.43, while 200 days put it at $18.02.
Levels Of Support And Resistance For CPRX Stock
The 24-hour chart illustrates a support level at 21.52, which if violated will result in even more drops to 21.29. On the upside, there is a resistance level at 22.16. A further resistance level may holdings at 22.57. The Relative Strength Index (RSI) on the 14-day chart is 49.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.64%. Stochastics %K at 50.68% indicates the stock is a holding.
How much short interest is there in Catalyst Pharmaceuticals Inc?
A steep rise in short interest was recorded in Catalyst Pharmaceuticals Inc stocks on 2024-11-15, dropping by -0.28 million shares to a total of 5.68 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 5.96 million shares. There was a decline of -4.96%, which implies that there is a negative sentiment for the stock.
